On the other hand, GLUT1 and LAT1 may be useful to deliver compounds into brain tumors, such as accumulating boron (10B) in the boron neutron capture therapy (BNCT), since GLUT1 and LAT1 are often overexpressed in many gliomas (136–138). This evidence concerns the gene SLC2A1 and central nervous system cancer.